New insights into coumarin-based MAO inhibitors for neurodegenerative diseases

Announcing a new publication for Acta Materia Medica journal. Monoamine oxidase (MAO) is a useful target in the treatment of neurodegenerative diseases and depressive disorders.

Leave a Reply